Prometheon Pharma, Llc

Description

• Prometheon Pharma has developed a transdermal platform technology called Topicon, specifically formulated for the creation of drug patch products that allow for truly passive delivery of large molecule drugs across the skin. We call them TruePatch because they don't use microneedles (often referred to as protrusions) to puncture the skin surface. A TruePatch is applied to the skin just like other prescription patches. It's truly that simple. Prometheon is developing convenient, painless, affordable, and truly needle-free TruePatch products, such as a basal insulin TruePatch to treat diabetes among increasing numbers of people, rich or poor, in every corner of the world. Prometheon is committed to finding simple and scalable biotechnology solutions for the complex health and social problems that threaten the public health and economy of every country in the world. For example, Prometheon is developing a novel class of anti-obesity drugs for the new millennium. Each of our innovations is intended to contribute to concerted efforts worldwide to move one step closer to achieving global health equity. As we align with organizations and individuals who share this same core value, we hope you will join us as partners, investors, or collaborators.Prometheon's Business Development Materials are available at https://app.box.com/s/79vbof3cfleecewpiwl4 1) Investor Pitch Decks (Download PPT file for animation and annotation)2) Business Plan (Download PDF file)3) Financial Projection Calculator (Download Excel File for full functionality)
• 

  Headquarters:3005 Southwest 70Th Lane , Gainesville, Florida, United States

  More
• 

  Phone Number: +1 386-418-0320

• 

  Website: https://www.prometheonpharma.com

• 

  Employees:3

• 

  Revenue:$0 - 1M

• 

  Legal Name:Prometheon Pharma, Llc

• Prometheon Pharma, Llc's Social Media

  
• Is this data correct?

• |  NAICS Code: 446110  |

  Show More